Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.171NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.57NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.279NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.279NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.610NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.610NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
AY.10 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.10 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.286NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.286NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.369NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.369NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.309NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.309NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.105NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.105NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.307NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.307NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
W.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
W.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GK.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.2.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.560NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.560NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used